Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$9.44 -0.05 (-0.58%)
As of: Nov 11, 2026 · 9:47 AM EST

Syndax Pharmaceuticals (SNDX) Receivables - Net (2024 - 2026)

Updated

Analysis

Syndax Pharmaceuticals (SNDX) Receivables - Net (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Syndax Pharmaceuticals 854.00 Mn -867.10 Mn 69.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 46.87 Mn
Jun 30, 2026 45.07 Mn
Mar 31, 2026 38.12 Mn
Dec 31, 2025 38.00 Mn
Sep 30, 2025 25.40 Mn
Jun 30, 2025 19.45 Mn
Mar 31, 2025 15.72 Mn
Dec 31, 2024 7.60 Mn
API Access

Syndax Pharmaceuticals Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=SNDX&period=max&api_key=YOUR_API_KEY